Qiagen Q1 Revenues Grow 12 Percent
April 25, 2012
Qiagen Q1 Revenues Grow 12 Percent
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- CMS Issues Pricing for MDx Codes; Labs, Test Developers Still Critical of Rates and Methodology
May 22, 2013 / Pharmacogenomics Reporter - Roche Receives FDA Nod for New PGx Indication for Tarceva in Metastatic NSCLC with Companion Dx
May 15, 2013 / Pharmacogenomics Reporter - Transgenomic to Develop RAS Mutation Test with Amgen for Metastatic CRC Patients
May 15, 2013 / Pharmacogenomics Reporter - Qiagen Buys Genomic Data Analysis Firm Ingenuity Systems for $105M
April 30, 2013 / GenomeWeb Daily News - Molecular Diagnostics Lifts Qiagen's Q1 Revenues 2 Percent
April 30, 2013 / GenomeWeb Daily News